Sham acupuncture: Patients in the non-meridian and non-acupoint group received sham acupuncture treatment at the position 2cm apart from the sensitized acupoint, once every other day for 30min each time, a total of 3 times for 1 week.
Acupuncture: Patients in acupoint sensitization group were treated with pseudoacupuncture at the sensitized points once every other day for 30min each time, a total of 3 times for 1 week.
Study summary
To investigate the changes of acupoint sensitization characteristics of patients with Neck Type Cervical Spondylopathy through Gallbladder meridian observe the curative effect of acupuncture intervention and optimize the clinical diagnosis and treatment plan of acupuncture treatment of Neck Type Cervical Spondylopathy
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Meeting the diagnostic criteria of Neck Type Cervical Spondylopathy.
* Age 18 to 65 years old gender is not limited.
* Clear awareness good compliance willing to cooperate with the study and accept the experimental arrangement.
* Physical examination may or may not be accompanied by positive signs of the musculoskeletal system (including limited motor function local tender points etc.).
* The visual analogue Scale (VAS) score was more than 3 points and less than 7 points (ranging from 0 to 10 points).
* Informed consent and sign informed consent.
Exclusion Criteria:
* It does not meet the diagnostic criteria and inclusion criteria of cervical spondylosis.
* Under 18 years of age or over 65 years of age;
* 2 weeks before the start of the experiment the relevant treatment of the disease or the use of relevant therapeutic drugs;
* Patients with other types of cervical spondylosis (cervical radiculopathy vertebral artery type cervical spondylosis cervical myelopathy sympathetic cervical spondylosis) or with other serious organic diseases and patients with neck and shoulder pain caused by non-neck diseases;
* Patients with cardiovascular and cerebrovascular liver kidney digestive system blood system and other serious life-threatening primary diseases or suffering from hemorrhagic diseases or skin diseases or pregnant or lactating women or have a history of cardiac pacemaker implantation;
* Previous history of neck surgery or neck fracture;
* Persons with confusion mental disorder or cognitive impairment;
* The skin at the test site has scars redness swelling heat and pain that affect the test result.
Primary outcome measure(s)
Visual Analogue Scale — Before the start of treatment, immediately after the end of the third treatment, and four weeks after follow-up The visual Analogue Scale (VAS) ranging from 0 to 10, with higher scores reflecting more pain, stiffness and poorer physical function of the Cervical. Participants were asked to evaluate their current pain, and the pain nature was marked by X on the line above. 0 was classified as painless and 10 was classified as severe pain. The higher the score, the more obvious the pain.
Trial sites (1)
Facility
City
Region
Status
The Third Affiliated Hospital of Zhejiang Chinese Medicine University
Hangzhou
China
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.